2015 Aug 25
Already too late to stop costly radiotherapy and surgery technologies?
Jim Hu, M.D., discusses the need to assess functional and survival outcomes of robotic surgery among prostate cancer patients. Read more
2015 Aug 19
Stiffer breast tissue in obese women promotes tumors
A study by Claudia Fischbach, Andrew Dannenberg and others has found that obesity changes the consistency of breast tissue in ways that are similar to tumors, thereby promoting disease. Read more
2015 Aug 18
Gender has surprising influence on survival after pediatric brain tumor removal
A retrospective study of pediatric brain tumors by Jeffrey Greenfield, M.D., has found gender differences in survival outcomes. Read more
2015 Aug 17
Genomic profiling provides much-needed prognostic data in glioma
Howard Fine, M.D., comments on attempts by researchers and clinicians to better classify low-grade gliomas. Read more
2015 Aug 13
Oxaliplatin pre-, post-surgery extends DFS for patients with advanced rectal cancer
Heather Yeo, M.D., comments on a study about a combination treatment option for patients with locally advanced rectal cancer. Read more
2015 Aug 10
Leaders in cancer research and clinical care
The Meyer Cancer Center is featured in a set of invited commentaries in Clinical Oncology News. Read more
2015 Aug 04
$1m grant to support genomic study of prostate cancer progression
Mark Rubin, M.D., will lead an investigation into the genomics of prostate cancer progression. Read more
2015 Jul 28
Breathing new life into lung cancer research
Thoracic surgeon Brendon Stiles is slicing away at the science behind lung cancer metastasis. Read more
2015 Jul 23
End-of-Life chemotherapy may do more harm than good
Treating terminally ill cancer patients with chemotherapy in the months or weeks before their deaths was not found to improve patients' quality of life and may actually do more harm than good, according to a new study led by Holly Prigerson, Ph.D. Read more
2015 Jul 16
Karla Ballman named chief of biostatistics and epidemiology
Renowned biostatistician Karla Ballman, Ph.D., has been named chief of the Division of Biostatics and Epidemiology in the Department of Healthcare Policy and Research at Weill Cornell Medical College. Read more
2015 Jul 14
Immune cells recruited to support lung cancer growth
Lung cancers attract circulating immune cells to the tumor mass, where the cancer reprograms them to support its growth and progression, according to a study by Vivek Mittal and colleagues. Read more
2015 Jul 13
Improving the odds for people with Non-Hodgkin Lymphoma
Peter Martin, M.D., is leading Weill Cornell participation in a multi-institutional, $11m NCI study Read more
2015 Jul 10
Targeting copper to treat breast cancer
The promise - and challenges - of copper depletion therapy for triple negative breast cancer. Read more
2015 Jul 07
All aboard: Will molecular tumor boards help cancer patients?
Mark Rubin, M.D., director of the Institute for Precision Medicine, discusses molecular tumor boards. Read more
2015 Jul 07
Varmus returns to his roots in cancer genetics
Harold Varmus, M.D., discusses his career and the future of cancer care in interviews with JAMA and Scientific American. Read more
2015 Jul 07
Absence of tumor-suppressing gene derails DNA replication
If tumor-suppressor gene PTEN has mutated or is absent, the DNA replication process derails and can lead to cancer development, according to a new study by Wen Shen, Ph.D. Read more
2015 Jul 04
Doublets match triplet regimens in transplant-ineligible myeloma
Double-drug therapy may be just as effective as triple-drug therapy, with less toxicity, for some patients with transplant-ineligible multiple myeloma, according to a study by Ruben Niesvizky, M.D. Read more
2015 Jul 02
A new method to diagnose an aggressive prostate cancer subset
Himisha Beltran, M.D., developed an 81-gene classifier that enables diagnosis of the complex and variable neuroendocrine subclass of treatment-resistant prostate cancer. Read more
2015 Jul 01
A new angle: Attacking DIPG
Mark Souweidane, M.D., is on the front lines of research into DIPG, a rare brain tumor that kills 250 children every year in North America. Read more
2015 Jun 30
Changing Treatment Landscape in CLL
The treatment landscape for individuals with chronic lymphocytic leukemia (CLL) has evolved dramatically over the past few years, according to Richard Furman, M.D. Read more
